- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on CD20-positive Non-Hodgkin Lymphoma
Total 5701 results
-
Hebei Senlang Biotechnology Inc., Ltd.Hebei Medical University Fourth HospitalRecruiting
-
Seoul National University HospitalNot yet recruitingDiffuse Large B Cell Lymphoma | Refractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaKorea, Republic of
-
St. Jude Children's Research HospitalCompletedLymphoblastic LymphomaUnited States
-
Hebei Senlang Biotechnology Inc., Ltd.RecruitingRefractory Indolent Adult Non-Hodgkin LymphomaChina
-
Timmune Biotech Inc.Hunan Provincial People's HospitalUnknownLeukemia | Non-Hodgkin Lymphoma of IntestineChina
-
Cellular Biomedicine Group Ltd.Shanghai Tongji Hospital, Tongji University School of MedicineUnknownRefractory or Relapsed Non-Hodgkin LymphomaChina
-
Shandong Lanjin Pharmaceuticals Co.,LtdUnknownNon-Hodgkin Lymphoma by Clinical CourseChina
-
AmgenCompletedB-Cell Non Hodgkin LymphomaUnited States, Spain, United Kingdom, Belgium, Italy, Australia, Canada, Puerto Rico
-
Novartis PharmaceuticalsCompleted
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLCTerminated
-
John ReneauRecruitingRecurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Recurrent Adult T-Cell Leukemia/Lymphoma | Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Refractory Adult T-Cell Leukemia/LymphomaUnited States
-
NCIC Clinical Trials GroupCompleted
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaMacedonia, The Former Yugoslav Republic of
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaSpain, France, United Kingdom, Germany, Australia, Italy
-
Hoffmann-La RocheCompletedA Study of MabThera/Rituxan (Rituximab) in Patients With Non-Bulky Follicular Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaFrance
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaFrance, Italy, Australia, Canada, Sweden, Switzerland
-
BiogenTerminatedLymphoma, Non-Hodgkin's
-
BiogenTerminated
-
French Innovative Leukemia OrganisationUnknown
-
French Innovative Leukemia OrganisationUnknown
-
BiogenTerminatedLymphoma, Non-Hodgkin'sUnited States
-
Medical University of South CarolinaRecruitingChronic Lymphocytic Leukemia | B-cell Non Hodgkin LymphomaUnited States
-
Amgen Research (Munich) GmbHCompletedNon-Hodgkin's Lymphoma, RelapsedGermany
-
Nanjing Yoko Biomedical Co., Ltd.CompletedB-Cell LymphomaChina
-
AbbVieInfinity Pharmaceuticals, Inc.WithdrawnChronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | Small Lymphocytic LymphomaUnited States
-
Lundbeck Canada Inc.CompletedChronic Lymphocytic Leukemia | Indolent Non-Hodgkin's LymphomaCanada
-
Lymphoma Study AssociationCompleted
-
National Cancer Institute (NCI)CompletedAlisertib and Romidepsin in Treating Patients With Relapsed or Refractory B-Cell or T-Cell LymphomasRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Recurrent Mantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma With... and other conditionsUnited States
-
Jurgen BarthSponsor GmbHActive, not recruitingNon-Hodgkin's Lymphoma | Lymphocytic Lymphoma | Marginal Zone Lymphomas | Follicular Lymphomas | Immunocytomas | Mantle-Cell LymphomasGermany
-
CelgeneActive, not recruitingLymphoma, Non-HodgkinUnited States, Italy, Austria, Canada, France, Germany, Japan, Spain, Sweden, United Kingdom
-
CephalonCompletedNon-Hodgkin's Lymphoma (NHL)United States, Belgium, Israel
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Genentech, Inc.Completed
-
SCRI Development Innovations, LLCGenentech, Inc.CompletedLymphoma, FollicularUnited States
-
European Organisation for Research and Treatment...Stichting Hemato-Oncologie voor Volwassenen Nederland; Lymphoma Trials OfficeTerminated
-
GlaxoSmithKlineCompletedNon-Hodgkin's LymphomaUnited States
-
Shanghai YingLi Pharmaceutical Co. Ltd.UnknownLymphoma, FollicularChina
-
National Cancer Institute (NCI)RecruitingRefractory B-Cell Non-Hodgkin Lymphoma | Refractory T-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Transformed Non-Hodgkin Lymphoma | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Recurrent T-Cell Non-Hodgkin Lymphoma | Recurrent Primary Cutaneous... and other conditionsUnited States
-
PrECOG, LLC.Genentech, Inc.TerminatedIndolent Non-Hodgkin's LymphomaUnited States
-
Sun Yat-sen UniversityCompletedChildhood Non-Hodgkin's Lymphoma
-
Autolus LimitedRecruitingRelapsed or Refractory B Cell Acute Lymphoblastic Leukemia | Relapsed or Refractory B Cell Non-Hodgkin LymphomaUnited Kingdom
-
The First Affiliated Hospital of Soochow UniversityFundamenta Therapeutics, Ltd.RecruitingB Cell Lymphoma | CAR | Relapsed Non-Hodgkin LymphomaChina
-
BayerCompletedLymphoma, B-Cell | Non-Hodgkin's Lymphoma | Lymphoma, Low-GradeJapan
-
Université de SherbrookeUnknownLymphoma, Large-CellCanada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRefractory Hodgkin Lymphoma | Refractory T-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent T-Cell Non-Hodgkin LymphomaUnited States
-
Burzynski Research InstituteTerminatedNon Hodgkin LymphomaUnited States
-
Case Comprehensive Cancer CenterTerminatedPrimary Central Nervous System Non-Hodgkin LymphomaUnited States
-
Fondazione Italiana Linfomi ONLUSRecruiting